The Jon Block Group Collaborates With Vivonoetics Inc. in Testing New Body Sensors

Sept. 20, 2012 - PRLog -- The Jon Block Group announced today that it is engaged in testing new physiological monitoring sensors in optimizing rider performance in motorcycle racing.  Jon Block Group Sports sponsored rider Wyatt Farris will work with the team at Vivonoetics in testing the newest physiological sensors at upcoming races, racing practice, and during intensive coaching workshops.

Farris will be using the state-of-the-art Equivital EQ-02 sensor platform, a wearable sensor platform which will continuously monitor heart rate, breathing, posture, movement and temperature.  The EQ-02 system integrates sensors in a comfortable garment worn directly against the skin, under protective racing clothing that is able to simultaneously acquire ECG, respiration and tri-axial accelerometry data.  Wyatt’s physiological data will be visualized, and analyzed, in Vivonoetics’ proprietary software VivoSense®, which is also used by researchers at USAF, US Army Research Laboratory, Harvard University, and Mayo Clinic.  

“Monitoring the physiology of elite athletes like Wyatt, using state-of-the-art technologies, enables us to push the limits of human performance, while simultaneously ensuring the health and well being of our team”  stated Kurt Burgess, head of business development for The Jon Block Group.

About Vivonoetics

Founded in San Diego in 2009, Vivonoetics is a provider of ambulatory physiological sensors, VivoSense® analysis software, and specialist Data Management services for pharmaceutical clinical trials, academic institutions and governmental researcher teams. For more information, please visit http://vivonoetics.com.

About The Jon Block Group

The Jon Block Group is an internationally recognized clinical affairs consulting firm based in San Francisco specializing in orthopedic medical devices with emphasis on the spine, including treatments for sports-related injuries. Their primary mission is to expedite regulatory approval and clinical acceptance of emerging and cutting-edge technologies. For more information visit http://www.jonblockgroup.com.